 SOUTH SAN FRANCISCO, Calif., Aug. 31, 2022 GLOBE NEWSWIRE -- Vaxart, Inc. Nasdaq: VXRT today announced it will release top-line data from the first part of its planned two-part COVID-19 Phase II trial of its Wuhan S-only construct before the market open on Thursday, September 1, 2022. The Vaxart senior management team will host a live conference call and webcast beginning at 8:30 a.m. Eastern Time on the same date to review the data and provide a trial update. 